What is NDC 72205-167?

72205-167 is the product NDC for Olmesartan medoxomil, Olmesartan medoxomil 40 mg/1 tablet, film coated, listed with the FDA by Novadoz Pharmaceuticals LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.

Novadoz Pharmaceuticals LLC, NDC labeler code 72205. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Olmesartan medoxomil?

119 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Olmesartan medoxomil NDC 72205-167 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72205-167Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72205-0167Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
72205-167-30	72205016730	30 TABLET, FILM COATED in 1 BOTTLE (72205-167-30)Marketed from Dec 18, 2023
72205-167-66	72205016766	1000 TABLET, FILM COATED in 1 BOTTLE (72205-167-66)Marketed from Feb 16, 2024
72205-167-90	72205016790	90 TABLET, FILM COATED in 1 BOTTLE (72205-167-90)Marketed from Dec 18, 2023
72205-167-99	72205016799	10 BLISTER PACK in 1 CARTON (72205-167-99) / 10 TABLET, FILM COATED in 1 BLISTER PACK (72205-167-11)Marketed from Dec 18, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Olmesartan medoxomil
Generic name (nonproprietary): olmesartan medoxomil
Active ingredients: Olmesartan medoxomil — 40 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Novadoz Pharmaceuticals LLCNDC labeler code 72205
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217399
Marketing start: Jan 18, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 72205-167_c81a0bea-32c1-4a0a-ac3c-5afe99cecdf2SPL ID c81a0bea-32c1-4a0a-ac3c-5afe99cecdf2SPL set ID 4238a064-1bfd-4ce3-b9d9-12c96eee8af0RxCUI 349373, 349401, 349405UNII 6M97XTV3HDUPC 0372205166660, 0372205165908, 0372205166905, 0372205167902, 0372205165663, 0372205166301, 0372205167308, 0372205165304, 0372205167667
Pharmacologic class: Angiotensin 2 Receptor Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472205016730 followed by a unit qualifier and the quantity

Package 72205-0167-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 30, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

Olmesartan medoxomil tablets are indicated for the treatment of hypertension in adults and children six years of age and older, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with olmesartan medoxomil. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72205-167

What is NDC 72205-167?: 72205-167 is the product NDC for Olmesartan medoxomil, Olmesartan medoxomil 40 mg/1 tablet, film coated, listed with the FDA by Novadoz Pharmaceuticals LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Olmesartan medoxomil.
What is the active ingredient?: Olmesartan medoxomil.
Who is the labeler?: Novadoz Pharmaceuticals LLC, NDC labeler code 72205. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Olmesartan medoxomil?: 119 other product NDCs are listed under this name. See all Olmesartan medoxomil NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Olmesartan medoxomil NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Olmesartan medoxomil	Olmesartan medoxomil 5 mg/1	TabletOral	NorthStar RxLLC	72603-950	72603-0950-0172603-0950-02
Olmesartan medoxomil	Olmesartan medoxomil 20 mg/1	TabletOral	NorthStar RxLLC	72603-951	72603-0951-0172603-0951-02
Olmesartan medoxomil	Olmesartan medoxomil 40 mg/1	TabletOral	NorthStar RxLLC	72603-952	72603-0952-0172603-0952-02
Olmesartan Medoxomil	Olmesartan medoxomil 5 mg/1	Tablet, Film coatedOral	HEC Pharm USA Inc.	72303-0848	72303-0848-0172303-0848-02
Olmesartan Medoxomil	Olmesartan medoxomil 20 mg/1	Tablet, Film coatedOral	HEC Pharm USA Inc.	72303-0849	72303-0849-0172303-0849-02
Olmesartan Medoxomil	Olmesartan medoxomil 40 mg/1	Tablet, Film coatedOral	HEC Pharm USA Inc.	72303-0850	72303-0850-0172303-0850-02
Olmesartan medoxomil	Olmesartan medoxomil 20 mg/1	TabletOral	REMEDYREPACK INC.	70518-4598	70518-4598-00
Olmesartan Medoxomil	Olmesartan medoxomil 5 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-009	60290-0009-0160290-0009-0260290-0009-03
Olmesartan Medoxomil	Olmesartan medoxomil 20 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-010	60290-0010-0160290-0010-0260290-0010-03
Olmesartan Medoxomil	Olmesartan medoxomil 40 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-011	60290-0011-0160290-0011-0260290-0011-03

All 120 Olmesartan medoxomil NDCs

Other NDCs under ANDA 217399

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217399
Product	Strength	Form · route	Labeler	Product NDC
Olmesartan medoxomil	Olmesartan medoxomil 5 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-3162
Olmesartan medoxomil	Olmesartan medoxomil 5 mg/1	Tablet, Film coatedOral	Novadoz Pharmaceuticals LLC	72205-165
Olmesartan medoxomil	Olmesartan medoxomil 20 mg/1	Tablet, Film coatedOral	Novadoz Pharmaceuticals LLC	72205-166